Additionally, we found that CD39i treatment increased the proportion of tumor infiltrated cDC1 (Fig. 5D and Supplementary Fig. 10D, E), XCR1 + cDC1 (Supplementary Fig. 10F, G) as well as the tumor Xcl1 protein levels (Supplementary Fig. 10H) in control mice, but not in NK cell absent mice. The gene discussed is MPPE1; the disease is neoplasm.